Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Transplantation ; 82(6): 788-93, 2006 Sep 27.
Article in English | MEDLINE | ID: mdl-17006326

ABSTRACT

BACKGROUND: Cornea graft recipients are exposed to viral transmission from the donor. Cadaveric donor serum is often of poor quality and frequently yields falsely positive results in serological assays that may result in the graft being needlessly discarded. OBJECTIVE: We examined the influence of the time of blood collection after death, and the macroscopic aspect of serum, on serological test results in cadaveric cornea donors. METHODS: Five hundred sixty-five consecutive cadaveric cornea donors were systematically tested for serological markers of human immunodeficiency virus type 1 and 2, human T-cell leukemia virus type 1, hepatitis B and hepatitis C viruses (HCV). We studied the influence of the macroscopic aspect of the donor's serum and the time of blood collection after death on the results of serological testing and on the subsequent decision to use or discard the graft. RESULTS: Twenty-one and a half percent of corneas were rejected on the basis of virological test results. We found significant relationships between the macroscopic aspect of serum at the time of testing and: (i) a positive, equivocal or discrepant result of immunoassays, for all markers except anti-HCV antibodies, (ii) non acceptance of cornea grafts, and (iii) the time of blood sampling after death. CONCLUSIONS: The macroscopic aspect of postmortem blood samples is the best predictor of the specificity of serological testing in cornea donors. Serological results should be interpreted with care when serum is macroscopically abnormal, and cadaveric donors should not be sampled more than 12 hr after death.


Subject(s)
Cornea , Tissue Donors , Cadaver , Cornea/abnormalities , Cornea/pathology , Cornea/virology , HIV/isolation & purification , HIV-1/isolation & purification , Hepacivirus/isolation & purification , Hepatitis B virus/isolation & purification , Human T-lymphotropic virus 1/isolation & purification , Humans , Living Donors
2.
Lancet ; 364(9445): 1611-2, 2004.
Article in English | MEDLINE | ID: mdl-15519632

ABSTRACT

The objective of our study was to determine whether nucleic acid testing could detect HIV RNA or hepatitis C virus (HCV) RNA in a large series of seronegative organ and tissue donors, and whether this technique should be routinely used to improve viral safety of grafts. We studied 2236 organ donors, 636 tissue donors, and 177 cornea donors. We identified five HCV RNA-positive donors in 2119 HCV-seronegative organ donors, and one HCV RNA-positive donor in 631 HCV-seronegative tissue donors. No HIV-seronegative, HIV RNA-positive donor was identified. Our data suggest that routine nucleic acid testing of organ and tissue donors might increase viral safety in transplantation.


Subject(s)
HIV Seronegativity , HIV/isolation & purification , Hepacivirus/isolation & purification , Hepatitis C Antibodies/blood , RNA, Viral/blood , Tissue Donors , Humans , Nucleic Acid Amplification Techniques
SELECTION OF CITATIONS
SEARCH DETAIL
...